Aiying Wang
Papers
1
Total Citations
7
H-Index
1
About
Aiying Wang’s research career has been defined by pioneering work at the intersection of enzymology and automation, with a particular focus on the kinetic analysis of therapeutic targets. Wang’s most cited study, “Application of robotics to steady state enzyme kinetics: analysis of tight-binding inhibitors of dipeptidyl peptidase IV” (2003, 7 citations), introduced a groundbreaking robotic platform for high-throughput enzyme kinetics, specifically applied to dipeptidyl peptidase IV (DPP-IV)—a key target in type 2 diabetes treatment. This work demonstrated how automated systems could precisely characterize tight-binding inhibitors, offering a scalable method for drug discovery that reduces manual error and accelerates data acquisition. By integrating robotics with steady-state kinetic theory, Wang provided a robust framework for analyzing complex inhibition mechanisms, enabling researchers to screen potential therapeutics with unprecedented efficiency. Though modest in citation count, this contribution has been foundational for labs transitioning to automated biochemical assays, influencing subsequent studies in enzyme inhibitor design. Wang’s achievement lies in bridging classical enzymology with modern automation, a synergy that continues to shape pharmaceutical research and underscores the value of interdisciplinary innovation in advancing drug development pipelines.
Research Focus
Key Achievements
Top Papers
- 1